Clincosm LogoSign in Get a demo

her2 gene mutation

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Cancer, Gastric Adenocarcinoma, HER2 Gene Mutation Trial in United States (Pembrolizumab, Trastuzumab)

Not yet recruiting
  • Esophageal Cancer
  • +2 more
  • Baltimore, Maryland
  • +8 more
Nov 3, 2023

Metastatic Cancer, HER2 Gene Mutation Trial in Seoul (Neratinib Maleate)

Active, not recruiting
  • Metastatic Cancer
  • HER2 Gene Mutation
  • Neratinib Maleate
  • Seoul, Korea, Republic of
    Korea university Guro hospital
Oct 18, 2023

HER2 Gene Mutation Trial in Shanghai (Injection of IAH0968+Gemcitabine+Cisplatin, Gemcitabine+Cisplatin)

Recruiting
  • HER2 Gene Mutation
  • Injection of IAH0968+Gemcitabine+Cisplatin
  • Gemcitabine+Cisplatin
  • Shanghai, China
    Fudan University Affiliated Zhongshan Hospital
Aug 7, 2023

HER2 Gene Mutation Trial (Injection of IAH0968 + CAPEOX, PLACEBO+CAPEOX)

Not yet recruiting
  • HER2 Gene Mutation
  • Injection of IAH0968 + CAPEOX
  • PLACEBO+CAPEOX
  • (no location specified)
Jan 4, 2023

Salivary Gland Cancer, HER2 Gene Mutation Trial in Boston (Ado-trastuzumab (T) emtansine (T-DM1), Standard of Care Radiotherapy,

Recruiting
  • Salivary Gland Cancer
  • HER2 Gene Mutation
  • Ado-trastuzumab (T) emtansine (T-DM1)
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jan 2, 2023

HER2 Mutant NSCLC, HER2-positive Metastatic Breast Cancer, HER2 Gene Mutation Trial (ELVN-002, Fam-Trastuzumab Deruxtecan-Nxki,

Not yet recruiting
  • HER2 Mutant Non-small Cell Lung Cancer
  • +3 more
  • (no location specified)
Dec 6, 2022

HER2-positive Breast Cancer, HER-2 Protein Overexpression, HER-2 Gene Amplification Trial in San Antonio, Fairfax (ORM-5029)

Not yet recruiting
  • HER2-positive Breast Cancer
  • +3 more
  • San Antonio, Texas
  • +1 more
Aug 22, 2022

Non Small Cell Lung Cancer Metastatic, Non Small Cell Lung Cancer Stage III, HER2 Gene Mutation Trial in France (pertuzumab +

Active, not recruiting
  • Non Small Cell Lung Cancer Metastatic
  • +2 more
  • pertuzumab + trastuzumab + docetaxel
  • Besançon, France
  • +17 more
Mar 9, 2022

Solid Tumor, HER2 Gene Mutation, HER-2 Gene Amplification Trial in Tianjin (Pyrotinib)

Not yet recruiting
  • Solid Tumor
  • +3 more
  • Tianjin, Tianjin, China
    Tianjin Medical University Second Hospital
Nov 25, 2019

HER2 Gene Mutation, Adenocarcinoma Lung Stage IV Trial in Seoul (Poziotinib)

Completed
  • HER2 Gene Mutation
  • Adenocarcinoma Lung Stage IV
  • Seoul, Korea, Republic of
    Korean Association for the Study of Targeted Therapy
May 23, 2018

Breast Cancer, HER2 Gene Mutation Trial in Beijing (Pyrotinib)

Unknown status
  • Breast Cancer
  • HER2 Gene Mutation
  • Beijing, Beijing, China
    Fei Ma
Jan 28, 2018